Spectacles Lens in Concussed Kids

NCT ID: NCT03123822

Last Updated: 2022-06-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-31

Study Completion Date

2021-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We will be looking at 3 treatment arms in the form of different type of glasses to see if one is superior to helping kids have sustained a concussion and are symptomatic.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recent studies have shown children who sustain a concussion are susceptible to having chronic symptoms (post-concussion syndrome). This chronicity can lead to delays in returning to learn and returning to play. Blurry vision, double vision, eye strain and eye tracking problems are some of the reported chronic symptoms that can affect patients' daily activities. Concussion awareness has increased recently and there is a surge of interest to better understand and treat the symptoms of post-concussion syndrome. Currently, ocular treatment for patients are often empirically determined. Common treatments are vision therapy and/or bifocal glasses. There has yet to be any standardization or prospective studies looking into treatment for these concussed patients with ocular symptoms and findings. The objective of this protocol is to compare three different types of glasses (typical prescription glasses for kids, typical glasses for kids with anti-glare coating, and progressive addition lenses with anti-glare coating) as treatment options for participants who are still symptomatic four weeks out from their concussion. The main outcome is the effectiveness of these three different options in reducing patients' symptoms and improving the participants' visual findings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Concussion, Mild Convergence Insufficiency Accommodation; Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single vision glasses

Typical glasses prescribed for children to correct only distance refractive error and to be worn all waking hours.

Group Type EXPERIMENTAL

Glasses

Intervention Type DEVICE

Glasses traditionally prescribed for refractive error

Single vision glasses with anti-glare coating

Typical glasses prescribed for children to correct only distance prescription with anti-glare coating and to be worn all waking hours.

Group Type EXPERIMENTAL

Glasses

Intervention Type DEVICE

Glasses traditionally prescribed for refractive error

Eyezen

Commercially available, low-powered, progressive addition lenses glasses with anti-glare coating to be worn all waking hours

Group Type EXPERIMENTAL

Glasses

Intervention Type DEVICE

Glasses traditionally prescribed for refractive error

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Glasses

Glasses traditionally prescribed for refractive error

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sustained a concussion \> 6 weeks \< 16 weeks from date of initial visit
* Criteria for concussion: formally diagnosed by physician
* Minimum best corrected visual acuity: 20/25 in right and left eyes at distance and 20/30 both eyes at near
* Minimum Stereopsis: 500" global
* CISS score \> 16
* Refractive error at least + 0.50D sphere or cylinder
* Ability to clear \> 0.50 cycles per minute in monocular accommodative flipper of and binocular accommodative flipper of +/-1.50

Exclusion Criteria

* Diplopia from nerve palsies
* Retinal pathology
* Previous treatment of any amount of bifocal lenses and base in prism since concussion.
* Vision therapy \> 6 weeks since concussion
Minimum Eligible Age

9 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Katherine K Weise

Director of Pediatric Optometry Services

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Becky Luu, OD

Role: STUDY_DIRECTOR

University of Alabama at Birmingham

Katherine Weise, OD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama School of Optometry

Birmingham, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Assuring Ophthalmologic Follow up
NCT04959422 WITHDRAWN NA